China Pharma Holdings (CPHI) Profit After Tax Growth (1y) (2011 - 2026)
China Pharma Holdings (CPHI) Profit After Tax Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.78 Bn | 87.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 36.02 Bn | 32.28 Bn | 1.97 Bn | 67.73% |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn | -0.17% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -388.33% |
| 5 | United Therapeutics | 23.09 Bn | 20.94 Bn | 648.10 Mn | -14.68% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.35 Bn | 18.54 Bn | 1.16 Bn | 105.80% |
| 8 | Neurocrine Biosciences | 17.82 Bn | 16.50 Bn | 800.70 Mn | 1,682.88% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | -14.93% |
| 10 | China Pharma Holdings | 32.25 Mn | 32.08 Mn | 285,487.00 | 9.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.68% |
| Dec 31, 2025 | 3.01% |
| Sep 30, 2025 | 39.39% |
| Jun 30, 2025 | 63.26% |
| Mar 31, 2025 | 17.82% |
| Dec 31, 2024 | -24.28% |
| Sep 30, 2024 | -26.06% |
| Jun 30, 2024 | -142.51% |
| Mar 31, 2024 | -100.83% |
| Dec 31, 2023 | 56.31% |
| Sep 30, 2023 | 1.67% |
| Jun 30, 2023 | 33.25% |
| Mar 31, 2023 | 53.77% |
| Dec 31, 2022 | -129.93% |
| Sep 30, 2022 | 4.34% |
| Jun 30, 2022 | -7.72% |
| Mar 31, 2022 | -34.17% |
| Dec 31, 2021 | 18.88% |
| Sep 30, 2021 | -53.24% |
| Jun 30, 2021 | -4,475.62% |